Cart
sales@molnova.com
FITC-Dextran
CAS No. 60842-46-8
FITC-Dextran( —— )
Catalog No. M22499 CAS No. 60842-46-8
FITC-Dextran (MW 10000) is a marker consisting of coupling fluorescein-isothiocyanate to dextran (10 kDa).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 30 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 79 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFITC-Dextran
-
NoteResearch use only, not for human use.
-
Brief DescriptionFITC-Dextran (MW 10000) is a marker consisting of coupling fluorescein-isothiocyanate to dextran (10 kDa).
-
DescriptionFITC-Dextran (MW 10000) is a marker consisting of coupling fluorescein-isothiocyanate to dextran (10 kDa). FITC-Dextran can be used to determine ion, solute, and protein permeability of the blood-brain barrier (BBB) based on the size of the dextran used.
-
In Vitro——
-
In VivoGuidelines (Following is our recommended protocol. This protocol only provides a guideline, and should be modified according to your specific needs).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number60842-46-8
-
Formula Weight——
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityH2O:50 mg/mL (Need ultrasonic)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Natarajan R, et al. Fluorescein Isothiocyanate (FITC)-Dextran Extravasation as a Measure of Blood-Brain Barrier Permeability. Curr Protoc Neurosci. 2017 Apr 10;79:9.58.1-9.58.15.
molnova catalog
related products
-
PAR-4 Agonist Peptid...
PAR-4 Agonist Peptide, amide(2TFA) is an agonist of proteinase-activated receptor-4 (PAR-4).
-
Orotic Acid Monohydr...
Orotic acid is an intermediate product in pyrimidine metabolism.
-
Cdk4/6 Inhibitor IV
Cdk4/6 inhibitor IV is a cell-permeable triaminopyrimidine that reversibly blocks Cdk4/cyclin D1 and Cdk6/cyclin D1 activity with IC50 values of 1.5 and 5.6 μM, respectively.
